Tele: 561.316.3330
Breaking Medical Device News

Thursday, September 23, 2021
HomeSignifier Medical TechnologiesSignifier Medical Technologies Collaborates With Global Sleep Experts on Its Innovative Snoozeal® Device Clinical Trials

Signifier Medical Technologies Collaborates With Global Sleep Experts on Its Innovative Snoozeal® Device Clinical Trials

Signifier Medical Technologies today announced that it is partnering with twenty-seven Key Opinion Leaders in Sleep to test and build awareness around its Snoozeal® product in the lead up to its commercial launch. The company are innovators in the sleep-disordered breathing market

This research-focused initiative enhances Signifier Medical Technologies’ ability to fine-tune its revolutionary genioglossal muscle-neurostimulation technology and ensure that it meets the needs of patients around the world. It will also help refine internal commercial processes and ensure a seamless experience for future patients.

Key Opinion Leaders include top-tier physicians in key sleep therapeutic areas, including pulmonologists, cardiologists, neurologists and ear, nose and throat (ENT) specialists from leading health academies and institutions in North America, Europe and Australia. Signifier Medical Technologies is working with these medical professionals to build a large acceptance of the efficacy and the safety of this new technology and create a large multi-center clinical dataset that will further expand on the recent trials in Europe and United States.

Professor Atul Malhotra, Chief Investigator at the University of CaliforniaSan Diego for Snoozeal® mentioned the enthusiasm for having a new technology in this space. “I have been involved with the Snoozeal® device and have been doing ongoing research on this treatment. I am optimistic that this treatment will be an important treatment approach for patients with snoring and with mild sleep apnoea.”

“I have been very surprised by this device. The feedback and adherence from patients have been excellent, reporting an improvement in their snoring. The integration between the app and the device work is smooth, easy, and intuitive.” Dr. Peter M Baptista, MD, Ph.D. mentioned after using the device in some of his patients in Clínica Universidad de Navarra.

“We are pleased to work with professionals from some of the world’s top medical and academic institutions to revolutionize the sleep market,” said Prof Anshul Sama, co-founder, and CMO of Signifier Medical Technologies. “Our work together could impact the respiratory health of hundreds of millions of people and incorporates the latest and most innovative research in the field.”

These latest collaborations are an important step towards the global commercialization of Signifier Medical Technologies’ Snoozeal® product; currently commercially tested in the UK market.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy